Company Search:
Advanced Search
Sponsored Links
RegeneRx Biopharmaceuticals, Inc. Company Snapshot
RegeneRx Biopharmaceuticals, Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares RegeneRx Biopharmaceuticals with three other companies in this sector in the United States: Acadia Pharmaceuticals, Inc. (2015 sales of $61,000.00 of which 100% was Molecular Drugs), Endocyte, Inc. ($70,000.00 ), and Cocrystal Pharma Inc ($78,000.00 ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
RegeneRx Biopharmaceuticals, Inc.
  Stock Performance Chart for RegeneRx Biopharmaceuticals, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (3/23/2017): .31
(Figures in U.S. Dollars)
1 Week -3.1%   13 Weeks 3.3%  
4 Weeks -0.3%   52 Weeks -55.1%  
RegeneRx Biopharmaceuticals, Inc. Key Data:
  Ticker: RGRX Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 60,612
(Year Ending Jan 2016).
Employees: 5
  Currency: U.S. Dollars Market Cap: 33,104,017
  Fiscal Yr Ends: December Shares Outstanding: 106,787,151
  Share Type: Common Closely Held Shares: 54,116,336
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.